GSCF-2022

Introduction to GSCF-2022

Global Summit of Cancer Frontier-2022 offers unparalleled business, research opportunities and access to new markets in Cancer, Medicine and Health Care industry. Be on the cutting edge of new and often yet unreleased information and discover an area that piques your interest. Join us and witness the industry by participating at GSCF-2022 in Tokyo, Japan and give your career and business access to new opportunities from throughout the world.
Program covers the latest discoveries across the spectrum of Basic Oncological Research, Immuno-Oncology, Frontier of Clinical Oncology, Advances in Organ Site Research, Cancer Prevention, Early Detection, and Interception, Cancer Technology, Frontiers of Cancer Diagnostics/Therapeutics, and Late Breaking and Clinical Trials—and highlights the work of the best minds in research and medicine from Academicians, Doctors, Study sponsors, Related Associations & Societies; Executives from Bio-Engineering, Diagnosis Tools, Medical Devices and Pharmaceutical industries around the world.

Program Layout

Program Layout
	Plenary Lectures: Opening Ceremony and Keynote Forum l Breaking Research in Oncology l IO Landscape l Emerging Oncological Targets l Small Molecule Cancer Drug Discovery l Pipeline of Big Pharma Briefing l Precision Oncology l Regulatory and Policy in Oncology and Cancer Drug R & D l Best Practice in Clinical Oncology
	Stream 1: Basic Oncological Research	Stream 6: Cancer Technology and New Drugs R & D
	Stream 2: Immuno-Oncology	Stream 7: Frontiers of Cancer Diagnostics/Therapeutics
	Stream 3: Frontier of Clinical Oncology	Stream 8: Late Breaking and Clinical Trials
	Stream 4: Advances in Organ Site Research	Stream 9: Japanese Oncological Research Frontier
	Stream 5: Cancer Prevention, Early Detection, and Interception	Stream 10: Social and Cultural Activities

Renowned Speakers

Dr. G Mike Makrigiorgos, , Professor and Director, Medical Physics & Biophysics, Radiation Oncology, Dana Farber Cancer Institute, Harvard Medical School, USA	Dr. Carin A.Hagberg, Professor; Chief Academic Officer; Division Head, University of Texas MD Anderson Cancer Center, USA	Dr. Tom Blundell, Professor, University of Cambridge, UK
Dr. A. C. Matin, Professor, Stanford University School of Medicine, USA	Dr. Paul A. Insel, Distinguished Professor of Pharmacology and Medicine, University of California, San Diego, USA	Dr. Ahmet Gurakar, Medical Director of Liver Transplantation, The Johns Hopkins University, USA
Dr. Alvaro Macieira-Coelho, Professor, INSERM, France	Dr. Douglas W. Sborov, Director, Huntsman Cancer Institute, University of Utah, USA	Dr. Sandra Sephton, Professor, University of Louisville; Brown Cancer Center, USA
Dr. Luzhe Sun, Professor, University of Texas Health Science Center at San Antonio, USA	Dr. Ashok Jain, Professor, Albany State University, USA	Dr. Daniel Mark Siegel,Clinical Professor of Dermatology, SUNY Downstate Health Sciences University, USA
Dr. Salman M. Hyder, Professor, University of Missouri, USA	Dr. Beiyun Chen, Associate Professor, Mayo Clinic, USA	Dr. Sabino Zani, Surgical Oncologist, Davis Ambulatory Surgical Center; Duke University Medical Center, USA
Dr. Heinz Lubenau, CEO, Vaximm AG, Germany	Dr. Thomas Justel, Professor, FH Munster University of Applied Sciences, Germany	Dr. Yves Rozenholc, Head of Research Unit UR7537 - BioSTM, Université de Paris, France
Dr. Ralph Alexander Schmid, Professor, Bern University Hospital; University of Bern, Switzerland	Dr. Stephan Bodis, Professor, University Hospital Zurich & Cantonal Hospital Aarau, Switzerlandn	Dr. Mark Gorrell, Professor, The University of Sydney, Australia
Dr. Craig Kukard, Director, Head, Central Coast Cancer Centre; University of Newcastle, Australiad	Dr. Severino Rey, Professor, Manises Hospital; Synlab Iberia, Spain	Dr. Bai Xianhong, Chairman, Biotech Pharmaceuticals Co Ltd, China
Dr. Daxiang Cui, Distinguished Professor, Shanghai Jiao Tong University, China	Dr. Minoru Yamakado, Professor, Ashikaga University; Center for Multiphasic Health Testing and Services, Mitsui Memorial Hospital, Japan	Dr. Miri Ziv, Vice Chairman, Israel Cancer Association, Israela
Dr. Yi Sun, Professor, University of Michigan, Comprehensive Cancer Center, USA	Dr. Ashok Srivastava, Chief Medical officer, Immuno-Oncology, Hematology and Oncolytic Virus Therapy, Trans Atlantic Therapeutics, USA	Dr. Abdelhabib Semlali, Professor, Laval University, Canada

Exhibition and Poster

As part of the Global Summit of Cancer Research-2022, exhibition is definitely a unique opportunity for exhibitors demonstrating their branding products and cutting-edge technologies to attendees with interests. Our Coffee break and Poster Session will be standing in Exhibition Hall for attendees and clients with high convenience and comfort, while raising exhibitors’ profile and improving performance during the whole exhibition period.

Exhibition is open to all attendees from conference and worldwide targeting customers. There you will get more chances discussing and exploring details of every product, your specialists will be right around you.

Exhibition Date:
Set-up date: May 10, 2022
Show dates: 09:00-18:00, May 11-13, 2022
Place: Tokyo, Japan